Sorafenib in Advanced Hepatocellular Carcinoma
2008 · New England Journal of Medicine · 13K citations
https://doi.org/10.1056/nejmoa0708857
A
Alejandro Forner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
262
Papers
55.3K
Citations
50
h-index
107
i10-index
Alejandro Forner is an academic researcher from Hospital Clínic de Barcelona. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 50, co-authored 223 publications.
ORCID: 0000-0002-9014-4950Papers by this author
worksEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 · Journal of Hepatology · 11K citations
https://doi.org/10.1016/j.jhep.2018.03.019
Hepatocellular carcinoma
2012 · The Lancet · 4,009 citations
https://doi.org/10.1016/s0140-6736(11)61347-0
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 · Journal of Hepatology · 3,880 citations
https://doi.org/10.1016/j.jhep.2021.11.018
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
2020 · Nature Reviews Gastroenterology & Hepatology · 2,374 citations
https://doi.org/10.1038/s41575-020-0310-z
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
2022 · Journal of Hepatology · 330 citations
https://doi.org/10.1016/j.jhep.2021.12.010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat